5 Key Takeaways
-
1
Ortho-k effectively slows myopia progression in children and teenagers, with a significant evidence base supporting its efficacy.
-
2
The treatment shows the strongest protective effect against rapid progression in children aged 6 to 8 years.
-
3
Ortho-k is unique in its ability to slow myopia progression in patients with moderate to high astigmatism.
-
4
The safety profile of ortho-k in children is high, with a lower risk of microbial keratitis compared to soft contact lenses.
-
5
Ortho-k provides quality-of-life benefits, with children reporting better vision and satisfaction compared to single-vision spectacles.
This content is an AI-generated, fully rewritten summary based on a published scholarly article. It does not reproduce the original text and is not a substitute for the original publication. Readers are encouraged to consult the source for full context, data, and methodology.